Ces Urol 2004, 8(3):49-52 | DOI: 10.48095/cccu2004022
Urological side effects of treatment with indinavir
- 1 AIDS Centrum, Infekční klinika FN Na Bulovce, Praha
- 2 urologické oddělení FN Na Bulovce, Praha
Introduction of protease inhibitors to the practice improved on the one hand the treatment possibilities of HIV infection, on the other hand appeared numerous serious side effects, which negatively influence the quality of life of patients with HIV infection. One of the serious side effects of treatment with the protease inhibitor indinavir is nephrolithiasis.
Keywords: HIV, indinavir, nephrolithiasis
Published: June 1, 2004
References
- Dieleman JP, Sturkenboom MC, Jambroes M et al. Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the ATHENA cohort. Arch Intern Med 2002; 162: 1493-1501.
Go to original source... 
Go to PubMed... - Wu DS, Stoller ML. Indinavir urolithiasis. Curr Opin Urol 2000; 10: 557-561. Go to original source... Go to PubMed...
- Dieleman JP, van Rossum AM, Stricker BC et al. Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir. J Acquir Immune Defic Syndr 2003; 32: 135-142. Go to original source... Go to PubMed...
- Saltel E, Angel JB, Futter NG et al. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis. J Urol 2000; 164: 1895-1897. Go to original source... Go to PubMed...
- Sarcletti M, Petter A, Zangerle R. Indinavir and interstitial nephritis. Ann Intern Med 1998; 128: 320-321. Go to original source... Go to PubMed...
- Jaradat M, Phillips C, Yum MN et al. Acute tubulointerstitial nephritis attributable to indinavir therapy. Am J Kidney Dis 2000; 35: E16. Go to original source... Go to PubMed...
- Dieleman JP, Feltz van der M, Bangma CH et al. Papillary necrosis associated with the HIV protease inhibitor indinavir. Infection 2001; 29: 232-233. Go to original source... Go to PubMed...
- Rebassa Llull MJ, Conte VA, Grases FF et al. Anuria in HIV+ patients treated w indinavir. Arch Esp Urol 2000; 53: 719-721.
- Perazella MA. Drug-induced renal failure: update on new medications and unique mechanism of nephrotoxicity. Am J Med Sci 2003; 325: 349-362. Go to original source... Go to PubMed...
- Hirsch MS, Steigbigel RT, Staszewski S et al. Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection. Clin Infect Dis 2003; 37: 1119-1124. Go to original source... Go to PubMed...
- Crixivan Product Monograph. Merck Frosst Canada & Co, 2002.
- Herman JS, Ives NJ, Nelson M et al. Incidence and risk factors for the development of indinavir-associated renal complications. Journal of Antimicrobial Chemotherapy 2001; 48: 355-360. Go to original source... Go to PubMed...
- Bruce GR, Munch LC, Hoven AD et al. Urolithiasis associated with the protease inhibitor indinavir. Urology 1997; 50: 513-518. Go to original source... Go to PubMed...
- Kopp JB, Miller KD, Mican JA et al. Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med 1997; 127: 119-125. Go to original source... Go to PubMed...
- Nadler RB, Rubenstein JN, Eggener SE et al. The etiology of urolithiasis in HIV infected patients. J Urol 2003; 169: 475-477. Go to original source... Go to PubMed...
- Gagnon RF, Tecimer SN, Watters AK et al. Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir. Am J Kidney Dis 2000; 36: 507-515. Go to original source... Go to PubMed...
- Dieleman JP, Salahuddin S, Hsu YS et al. Indinavir crystallization around the loop of Henle: experimental evidence. J Acquir Immune Defic Syndr 2001; 28: 9-13. Go to original source... Go to PubMed...
- Martínez E, Leguizamón M, Mallolas J et al. Influence of enviromental temperature on incidence of indinavir-related nephrolithiasis. Clin Inf Dis 1999; 29: 422-425. Go to original source... Go to PubMed...
- de Araujo M, Seguro AC. Trimethoprim-sulfamethoxazole (TMP/SMX) potentiates indinavir nephrotoxicity. Antivir Ther 2002; 7: 181-184. Go to original source...
- Malavaud B, Dinh B, Bonnet E et al. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B and C virus infection. Antivir Ther 2000; 5: 3-5. Go to original source...
- Gatti G, Vigano A, Sala N et al. Indinavir pharmacokinetics and pharmacodynamics in children with human immunodeficiency virus infection. Antimicrob. Agents Chemother. 2000; 44: 752-755. Go to original source... Go to PubMed...
- Meraviglia P, Angeli E, Del Sorbo F et al. Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index. AIDS 2002; 16: 2089-2093. Go to original source... Go to PubMed...
- Solas C, Basso S, Poizot-Martin I et al. High indinavir Cmin is associated with higher toxicity in patients on indinavir-ritonavir 800/100 mg twice-daily regimen. J Acquir Immune Defic Syndr 2002; 29: 374-377. Go to original source... Go to PubMed...
- Sarcletti M, Petter A, Romani N et al. Pyuria in patients treated with indinavir is associated with renal dysfunction. Clin Nephrol 2000; 54: 261-270.
- Gagnon RF, Tecimer SN, Watters AK et al. The natural history of leukocyturia associated with indinavir treatment in HIV+ individuals. Am J Nephrol 2000; 20: 448-454. Go to original source... Go to PubMed...
- Janík V, Knopová Z, Kašpárek L et al. Spirální CT v diagnostice ureterolitiázy. Čes Radiol 2003; 57: 55-63.
- Kalaitzis C, Dimitriadis G, Tsatidis T et al. Treatment of indinavir sulphate induced urolithiasis in HIV-positive patients. Int Urol Nephrol 2002; 34: 13-15. Go to original source... Go to PubMed...
- Deray G. Kidney stones and indinavir: Is there a connection? Perspectives in HIV/AIDS therapy 2001; 1: 1-8.